FOXO3 Pathway – Impact on Crohn’s , Rheumatoid Arthritis and Malaria

Human SNP Links Differential Outcomes in Inflammatory and Infectious Disease to a FOXO3-Regulated Pathway

Graphical Abstract – Audio Interview at Link

mTor Signalling – Graphic available as PDF file here

  • Highlights
  • Reanalysis of GWAS data identifies a SNP associated with outcome in Crohn’s disease
  • This SNP modulates inflammatory responses in monocytes via a FOXO3-driven pathway
  • The mild disease-associated allele reduces TNFα and increases IL-10 production
  • Prognosis in RA and malaria (also TNFα-related diseases) is also linked to this SNP


The clinical course and eventual outcome, or prognosis, of complex diseases varies enormously between affected individuals.

This variability critically determines the impact a disease has on a patient’s life but is very poorly understood.

Here, we exploit existing genome-wide association study data to gain insight into the role of genetics in prognosis.

We identify a noncoding polymorphism in FOXO3A (rs12212067: T > G) at which the minor (G) allele, despite not being associated with disease susceptibility, is associated with a milder course of Crohn’s disease and rheumatoid arthritis and with increased risk of severe malaria.

Minor allele carriage is shown to limit inflammatory responses in monocytes via a FOXO3-driven pathway, which through TGFβ1 reduces production of proinflammatory cytokines, including TNFα, and increases production of anti-inflammatory cytokines, including IL-10.

Thus, we uncover a shared genetic contribution to prognosis in distinct diseases that operates via a FOXO3-driven pathway modulating inflammatory responses.

This entry was posted in Autism, co-morbid, Immune System, Inflammation, Treatment. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s